NCT03284879 2025-09-08
Post-Marketing Surveillance Study of OTEZLA
Amgen
Completed
Clinical Trials
4 trialsNCT05588622 2023-07-13
Meru Health Program for Cancer Patients With Depression and Anxiety
Meru Health, Inc.
Phase NA Completed
NCT01402830 2013-02-11
Case-control Study- Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients (Fentanyl)
Janssen-Cilag, S.A.
Completed
NCT00774813 2008-10-17
Nexalin Therapy for the Treatment of Depressive Symptoms
Kalaco Scientific, Inc.
Phase 2 Completed